WHO relaunches investigation into COVID-19 origin

The World Health Organization is relaunching an investigation into the origin of the virus that causes COVID-19.

The WHO has been pressured by the Biden administration to renew its efforts to examine reports of where the virus came from. The Scientific Advisory Group for the Origins of Novel Pathogens, a new permanent panel, will help the WHO investigate future outbreaks and determine human activities that increase the risk of new diseases.

The news was first reported by The Wall Street Journal.

The WHO previously looked into the origin of COVID-19 earlier this year after reports suggested it possibly came from a Wuhan lab. Foreign experts urged China to take a series of actions, including “analyze blood banks, test farmworkers and further scrutinize the earliest suspected cases,” WSJ reported. It’s not clear if China performed any of these measures, and that original team of experts from the WHO has disbanded.

The WHO will now select a new team to relaunch its investigation, and the team is likely to include at least one American. However, China has not said if it will let in the new, larger team consisting of members from a wider range of countries. The Chinese government will be closely watching the selection of the new team, according to the WSJ.

It’s important to note the original WHO team concluded it was highly unlikely the virus escaped from a Wuhan lab. Still, calls for more scrutiny over the analysis have heightened.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”